Etay Ziv, MD PhD

Associate Attending
Memorial Sloan Kettering Cancer Center, United States

Presentation(s):

• Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET)

  Sunday, March 30, 2025
  3:54 PM – 4:03 PM CT

• Improved Local Control at the Cost of Reduced Lymphocyte Count: A Propensity Score-Matched Analysis of Yttrium-90 Radioembolization versus Hepatic Arterial Embolization for Hepatic Metastatic Melanoma

  Monday, March 31, 2025
  3:27 PM – 3:36 PM CT

• SF3B1 and BAP1 Mutations Predict Survival Outcomes in Metastatic Uveal Melanoma Treated with Hepatic Artery Embolization

  Tuesday, April 1, 2025
  3:45 PM – 3:54 PM CT